Inventor
ASHWELL SUSAN
US49 patents
⚠️ This page may combine multiple inventors who share the name “ASHWELL SUSAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
23 patentsUS10550098B2Feb 4, 2020
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC17 citations94
US10414752B2Sep 17, 2019
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC19 citations94
US10005734B2Jun 26, 2018
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC25 citations94
US9834539B2Dec 5, 2017
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC28 citations94
US9815817B2Nov 14, 2017
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC24 citations94
US9771349B2Sep 26, 2017
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC27 citations94
US9624175B2Apr 18, 2017
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC25 citations94
US9624216B2Apr 18, 2017
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC26 citations94
US11498913B2Nov 15, 2022
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations84
US10889567B2Jan 12, 2021
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC5 citations84
US10550099B2Feb 4, 2020
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations84
US10807976B2Oct 20, 2020
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC2 citations73
US10577329B2Mar 3, 2020
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations73
US10407419B2Sep 10, 2019
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC5 citations73
US11497743B2Nov 15, 2022
Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation
FORMA THERAPEUTICS INC3 citations72
US12275715B2Apr 15, 2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC0 citations63
US11963956B2Apr 23, 2024
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
FORMA THERAPEUTICS INC1 citations62
US11738018B2Aug 29, 2023
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
FORMA THERAPEUTICS INC1 citations62
US11576906B2Feb 14, 2023
Inhibiting mutant IDH-1
FORMA THERAPEUTICS INC1 citations62
US11376246B2Jul 5, 2022
Inhibiting mutant IDH-1
FORMA THERAPEUTICS INC1 citations62
US11311527B2Apr 26, 2022
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
FORMA THERAPEUTICS INC1 citations62
US11013734B2May 25, 2021
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
FORMA THERAPEUTICS INC1 citations62
US11013733B2May 25, 2021
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
FORMA THERAPEUTICS INC1 citations62
ELAN PHARM INC
11 patentsUS6479492B1Nov 12, 2002
Compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC41 citations95
US6794506B2Sep 21, 2004
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
ELAN PHARM INC30 citations92
US6689781B2Feb 10, 2004
Phenylalanine derivatives as alpha 4 integrin inhibitors
ELAN PHARM INC27 citations92
US6436904B1Aug 20, 2002
Compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC39 citations92
US7973044B2Jul 5, 2011
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC4 citations74
US7320960B2Jan 22, 2008
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC5 citations74
US7291645B2Nov 6, 2007
Phenylalanine derivatives as alpha 4 integrin inhibitors
ELAN PHARM INC7 citations74
US6525026B2Feb 25, 2003
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC9 citations74
US7968547B2Jun 28, 2011
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
ELAN PHARM INC2 citations63
US6803370B2Oct 12, 2004
Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4
ELAN PHARM INC4 citations63
US7745454B2Jun 29, 2010
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
ELAN PHARM INC0 citations52
WYETH CORP
6 patentsUS7378529B2May 27, 2008
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
WYETH CORP24 citations96
US6953802B2Oct 11, 2005
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
WYETH CORP13 citations84
US7015216B2Mar 21, 2006
Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
WYETH CORP8 citations74
US7229970B2Jun 12, 2007
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
WYETH CORP2 citations63
US6949570B2Sep 27, 2005
Compounds which inhibit leukocyte adhesion mediated by VLA-4
WYETH CORP2 citations63
US7223762B2May 29, 2007
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
WYETH CORP2 citations61
FORMA TM2 INC
4 patentsUS10280150B2May 7, 2019
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC19 citations93
US10266495B2Apr 23, 2019
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC19 citations93
US10253015B2Apr 9, 2019
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC20 citations93
US10294206B2May 21, 2019
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC7 citations83
(unassigned)
2 patentsATHENA NEUROSCIENCES INC
2 patentsUS6492421B1Dec 10, 2002
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
ATHENA NEUROSCIENCES INC52 citations92
US6291453B1Sep 18, 2001
4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
ATHENA NEUROSCIENCES INC20 citations84